- Home
- GMED
GMED
Globus Medical Inc.
as of 12-12-2025 3:55pm EST
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | AUDUBON |
| Market Cap: | 11.3B | IPO Year: | 2012 |
| Target Price: | $93.09 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.08 | EPS Growth: | 358.86 |
| 52 Week Low/High: | $51.79 - $94.93 | Next Earning Date: | 11-06-2025 |
| Revenue: | $2,769,804,000 | Revenue Growth: | 11.75% |
| Revenue Growth (this year): | 16.66% | Revenue Growth (next year): | 8.27% |
AI-Powered GMED Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Globus Medical Inc. (GMED)
Senior Vice President, CFO
Avg Cost/Share
$90.00
Shares
18,542
Total Value
$1,668,780.00
Owned After
0
SEC Form 4
Director
Avg Cost/Share
$86.00
Shares
25,000
Total Value
$2,150,005.00
Owned After
516,275
SEC Form 4
Director
Avg Cost/Share
$84.29
Shares
25,000
Total Value
$2,107,257.50
Owned After
0
SEC Form 4
Director
Avg Cost/Share
$85.00
Shares
2,000
Total Value
$170,000.00
Owned After
15,384
SEC Form 4
Director
Avg Cost/Share
$81.00
Shares
8,000
Total Value
$648,000.00
Owned After
15,384
SEC Form 4
Director
Avg Cost/Share
$58.46
Shares
10,000
Total Value
$584,600.00
Owned After
15,384
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Kline Kyle | GMED | Senior Vice President, CFO | Dec 1, 2025 | Sell | $90.00 | 18,542 | $1,668,780.00 | 0 | |
| Davidar David D | GMED | Director | Nov 12, 2025 | Sell | $86.00 | 25,000 | $2,150,005.00 | 516,275 | |
| ZARRILLI STEPHEN T | GMED | Director | Nov 11, 2025 | Sell | $84.29 | 25,000 | $2,107,257.50 | 0 | |
| RHOADS ANN D | GMED | Director | Nov 10, 2025 | Sell | $85.00 | 2,000 | $170,000.00 | 15,384 | |
| RHOADS ANN D | GMED | Director | Nov 7, 2025 | Sell | $81.00 | 8,000 | $648,000.00 | 15,384 | |
| RHOADS ANN D | GMED | Director | Sep 15, 2025 | Sell | $58.46 | 10,000 | $584,600.00 | 15,384 |
Compare GMED vs Leading Stocks
See how GMED stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GMED Globus Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.